|
Volumn 315, Issue 7109, 1997, Pages 676-
|
Impact of postmenopausal hormone therapy on cardiovascular events and cancer. More women are excluded from treatment arm of such trials because of cardiovascular events.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AGED;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL (TOPIC);
COHORT ANALYSIS;
ESTROGEN THERAPY;
FEMALE;
FOLLOW UP;
HUMAN;
MIDDLE AGED;
MORTALITY;
NEOPLASM;
NOTE;
TIME;
AGED;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
COHORT STUDIES;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
NEOPLASMS;
TIME FACTORS;
|
EID: 85007708202
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.315.7109.676 Document Type: Note |
Times cited : (4)
|
References (0)
|